Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Huazhong University of Science and Technology. Medical Sciences

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s11596-012-0005-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Valsartan

  2012cited by this paper
• Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

  2011cited by this paper
• Mutation of the protein kinase A phosphorylation site influences the anti-proliferative activity of mitofusin 2.

  2010cited by this paper
• Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells

  2008cited by this paper
• Mitofusin 2 Triggers Vascular Smooth Muscle Cell Apoptosis via Mitochondrial Death Pathway

  2007cited by this paper
• The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

  2006cited by this paper
• , and Significance in Vascular Smooth Muscle Cells Angiotensin II Signal Transduction Through Small GTP-Binding Proteins : Mechanism

  2006cited by this paper
• The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy

  2004cited by this paper
• Unravelling Ras signals in cardiovascular disease

  2004cited by this paper
• Dysregulation of HSG triggers vascular proliferative disorders

  2004cited by this paper
• Antiproliferative strategies for the treatment of vascular proliferative disease.

  2003cited by this paper
• Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism

  2003cited by this paper
• Angiotensin and vascular fibrinolytic balance.

  2002cited by this paper
• Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies

  2002cited by this paper
• Vascular inflammation and the renin-angiotensin system.

  2002cited by this paper
• Cyclin-dependent Kinase 2 Nucleocytoplasmic Translocation Is Regulated by Extracellular Regulated Kinase*

  2001cited by this paper
• Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade

  2001cited by this paper
• Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.

  2000cited by this paper
• Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

  2000cited by this paper
• Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery.

  1999cited by this paper
• Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells*

  1998cited by this paper
• Cloning and expression of a novel partial cDNA related to hypertension.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Cell cycle progression: new therapeutic target for vascular proliferative disease.

  1998cited by this paper
• Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.

  1998cited by this paper
• Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells

  1996cited by this paper

• Potential Crosstalk Between the Renin-Angiotensin System and Neuropilin-1 Pathways in Experimental Rheumatoid Arthritis.

  2026cites this paper
• Sacubitril/valsartan inhibits the proliferation of vascular smooth muscle cells through notch signaling and ERK1/2 pathway

  2024cites this paper
• Role of Mitochondrial Dynamics in Heart Diseases

  2023cites this paper
• Pers reverse angiotensin II -induced vascular smooth muscle cell proliferation by targeting cyclin E expression via inhibition of the MAPK signaling pathway

  2023cites this paper
• Current Understanding of the Pivotal Role of Mitochondrial Dynamics in Cardiovascular Diseases and Senescence

  2022cites this paper
• Biological evaluation of linalool on the function of blood vessels

  2021cites this paper
• Mitofusion 2 Overexpression Decreased Proliferation of Human Embryonic Lung Fibroblasts in Acute Respiratory Distress Syndrome through Inhibiting RAS-RAF-1-ERK1/2 Pathway

  2020cites this paper
• Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR

  2019cites this paper
• Epigallocatechin‐3‐gallate ameliorates hypoxia‐induced pulmonary vascular remodeling by promoting mitofusin‐2‐mediated mitochondrial fusion

  2017cites this paper
• Overexpression of Mitofusin2 decreased the reactive astrocytes proliferation in vitro induced by oxygen-glucose deprivation/reoxygenation.

  2017cites this paper
• Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells

  2015cites this paper
• Mitofusin2 decreases intracellular cholesterol of oxidized LDL-induced foam cells from rat vascular smooth muscle cells

  2013cites this paper